Brief: Cipla Says By CY 2026 Expect To Launch 4 Major Respiratory Assets
30/10/2025 07:43
Oct 30 (Reuters) - Cipla Ltd CIPL.NS: CIPLA - BY CY 2026 EXPECT TO LAUNCH 4 MAJOR RESPIRATORY ASSETS CIPLA - BY CY 2026 EXPECT TO LAUNCH GADVAIR, 3 PEPTIDE ASSETS, INCLUDING LIRAGLUTIDE Source text: ID:nBSEGTZF1 Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipla
See all newsIndian pharma stocks up on report US taps drugmakers for critical cancer drug
India's Cipla jumps after Citi sees near-term positive triggers for earnings
Factbox: Global drugmakers invest billions to boost US presence
India raises price cap on cancer drugs to tackle shortage
Brief: Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated